Femasys Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
FEMY Nasdaq 3840 www.femasys.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Femasys Inc.

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe - Nov 10th, 2025 7:00 am
BC-Most Active Stocks - Nov 3rd, 2025 8:30 am
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - Nov 3rd, 2025 6:30 am
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe - Oct 22nd, 2025 7:00 am
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo - Oct 16th, 2025 7:00 am
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership - Sep 25th, 2025 7:00 am
Femasys partners with Medical Electronic Systems for FemSperm kit - Sep 23rd, 2025 7:20 am
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed - Sep 22nd, 2025 7:00 am
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® - Sep 11th, 2025 7:00 am
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand - Sep 8th, 2025 7:00 am
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios - Sep 2nd, 2025 7:00 am
Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale - Aug 27th, 2025 10:02 am
Femasys Prices $8 Million Public Offering; Shares Slump Pre-Bell - Aug 26th, 2025 2:26 am
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering - Aug 25th, 2025 9:44 pm
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform - Aug 21st, 2025 7:00 am
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control - Aug 20th, 2025 7:00 am
Femasys Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Aug 11th, 2025 4:50 am
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates - Aug 8th, 2025 3:15 pm
Femasys Announces Second Quarter Financial Results for 2025 - Aug 8th, 2025 2:05 pm
Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - Aug 7th, 2025 7:25 am